Metabolites produced as intermediaries or end-products of microbial metabolism provide crucial signals for health and diseases, such as metabolic dysfunction-associated steatotic liver disease (MASLD). These metabolites include products of the bacterial metabolism of dietary substrates, modification of host molecules (such as bile acids [BAs], trimethylamine-N-oxide, and short-chain fatty acids), or products directly derived from bacteria. Recent studies have provided new insights into the association between MASLD and the risk of developing chronic kidney disease (CKD). Furthermore, alterations in microbiota composition and metabolite profiles, notably altered BAs, have been described in studies investigating the association between MASLD and the risk of CKD. This narrative review discusses alterations of specific classes of metabolites, BAs, fructose, vitamin D, and microbiota composition that may be implicated in the link between MASLD and CKD.
Citations
Citations to this article as recorded by
Radish Green Extract Attenuates Western Diet-Induced Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice Hye-Bin Lee, Yu Ra Lee, Eunjung Lee, Seong Un Jeong, Jae-Hyun Yoon, Miri Park, Yoonsook Kim, Ho-Young Park Journal of Agricultural and Food Chemistry.2026; 74(1): 874. CrossRef
Multi-omics reveal the key role of gut microbiota metabolism in adenine-induced chronic kidney disease Yijing Xin, Hui Ma, Xiang Li, Ruiyang Sun, Luo Fang, Libin Pan Toxicology and Applied Pharmacology.2026; 509: 117754. CrossRef
Research Progress on the Bile Acid Metabolome in Arteriovenous Fistula Stenosis among Maintenance
Hemodialysis Patients 佩 张 Advances in Clinical Medicine.2026; 16(03): 2204. CrossRef
Creatinine clearance rate predicts all-cause and cardiovascular mortality in patients with MASLD: a Shanghai cohort study Yingqi Hou, Yanqiu Huang, Chenghao Zhang, Wen Gu, Yadan Xu, Shuli Li, Jugang Wu, Jibin Liu, Honglin Liu Frontiers in Medicine.2026;[Epub] CrossRef
Plasma proteome profiling identifies XPNPEP3 as a novel biomarker associated with metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus Hua Ji, Yating Lu, Yichang Liu, Yinguang Jia, Jie Liu, Datong Deng, Mingwei Chen Annals of Medicine.2026;[Epub] CrossRef
Loss of immunometabolic adaptability in MASH: gut-derived signals drive macrophage reprogramming and fibrosis Yan Li, Yuyuan Hu, Yuan He, Yuhang Yang, Dingwen Xue, Erkui Xue, Jinghan Jia, Wei Zhang, Jinxi Wang Frontiers in Immunology.2026;[Epub] CrossRef
Ferroptosis in MASLD: From molecular mechanisms to therapeutic opportunities Xiao-Dong Zhou, Qiong-Yue Fan, Giovanni Targher, Christopher D. Byrne, Wei Xie, Qin-Fen Chen, Yuxing Dong, Fudi Wang, Daolin Tang, Ming-Hua Zheng Med.2026; 7(6): 101099. CrossRef
Classification of intestinal inflammation driven by gut microbiota metabolites: a new paradigm for precision treatment of cardiovascular diseases Dahua Zhao, Yanjun Cui, Zhen Hua Frontiers in Microbiology.2026;[Epub] CrossRef
Bile Acids and the Gut–X Axis: TCM-Mediated Systemic Protection and Therapeutic Opportunities for Multi-Organ Diseases Jialu He, Linjie Qin, Xian Sun Metabolites.2026; 16(6): 366. CrossRef
Association between metabolic dysfunction-associated steatotic liver disease/non-alcoholic fatty liver disease and chronic kidney disease: a systematic review and meta-analysis André O. Soares, Davi A. C. Loli, Gustavo R. Carvalho, Vinicius Daher Alvares Delfino, Paulo Roberto Bignardi Reviews in Endocrine and Metabolic Disorders.2026;[Epub] CrossRef
Global Prevalence, Incidence, and Outcomes of Coexisting MASLD and Chronic Kidney Disease: A Meta‐Analysis Martin T. W. Kueh, Jacob Kang Wen Yeo, Yiming Chen, Nicole Ying Zi Chua, Hui Lian Koh, Seng Pei Khaw, Hassan Jabbar, Jiong‐Wei Wang, Kwan Lee, Yip Han Chin, Dan Qin Sun, Alessandro Mantovani, Giovanni Targher, Nicholas W. S. Chew, Xiao‐Dong Zhou, Ming‐Hua Liver International.2026;[Epub] CrossRef
The Relationship Between Adherence to the Mediterranean Diet, Oxidative Stress, Trimethylamine N-Oxide, and Inflammatory Markers in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Saibe Merve Kazdal, Medeni Arpa, Çağlayan Keklikkiran, Sevinç Yücecan Nutrients.2026; 18(14): 2231. CrossRef
Hepatocyte hedgehog signaling controls ferroptosis to alleviate aging-related organ dysfunction Ji Hye Jun, Rajesh Kumar Dutta, Soon-Woo Cho, Rui Yao, Seh Hoon Oh, Zhi Li, Kuo Du, David S. Umbaugh, Nanchao Wang, Yirui Xu, Jingting Li, Lingyan Shi, Jen-Tsan Chi, Junjie Yao, Anna Mae Diehl JCI Insight.2026;[Epub] CrossRef
Bile acid signaling: from dynamic pool composition to inter-organ communication Fuyu Yang, Ting Wei, Kai Liu, Huikuan Chu, Ling Yang Frontiers in Endocrinology.2026;[Epub] CrossRef
Organ crosstalk in kidney diseases: Insights from metabolic, hormonal and nervous regulation Sen Lin, Shirong Zhu, Yi Fu Life Sciences.2026; 404: 124637. CrossRef
Quantifying inequalities and forecasting the burden of chronic kidney disease from 1990 to 2040 Xian Shao, Wenyi Jin, Mingzhen Pang, Ruixuan Chen, Ting Luo, Heping Zhang, Liming Pan, Kexin Ding, Shuxian Ma, Lili Zheng, Baozhen Huang, Pengpeng Ye, Sheng Nie, Xin Xu, Queran Lin iScience.2026; 29(9): 117273. CrossRef
Liver-Kidney Crosstalk in Major Pediatric Diseases: Unraveling the Complexities and Clinical Challenges Dario Piatto, Delia De Biasio, Francesco Giustino Cesaro, Gianmario Forcina, Vittoria Frattolillo, Antonio Colucci, Fabio Lamberti, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa Journal of Clinical Medicine.2025; 14(11): 3911. CrossRef
Altered mitochondrial function: a clue therapeutic strategies between metabolic dysfunction-associated steatotic liver disease and chronic kidney disease? Jiang Bai, Lijuan Zhang, Letian He, Yun Zhou Frontiers in Nutrition.2025;[Epub] CrossRef
Food Nutrients and Bioactive Compounds for Managing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review Erdenetsogt Dungubat, Kohei Fujikura, Masahiko Kuroda, Toshio Fukusato, Yoshihisa Takahashi Nutrients.2025; 17(13): 2211. CrossRef
Quyu Huazhuo Decoction alleviates non-Alcoholic steatohepatitis via remodeling the gut microbiota and regulating bile acid and short-chain fatty acid metabolism Lu Lu, Chengting Wu, Juhong Jia, Yuanqin Du, Yujiao Peng, Hongna Huang, Jingjing Huang, Yaobin Nong Journal of Chromatography B.2025; 1267: 124784. CrossRef
The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management Carlo Acierno, Riccardo Nevola, Fannia Barletta, Katarzyna Zielińska, Luca Rinaldi, Ferdinando Carlo Sasso, Caterina Conte, Luigi Elio Adinolfi, Alfredo Caturano Exploration of Medicine.2025;[Epub] CrossRef
Multiorgan crosstalk in MASLD/MASH: from hepatic pathogenesis to systemic complications Wenhua Bai, Zheng Zhu Frontiers in Endocrinology.2025;[Epub] CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis are Associated with Advanced Cardiovascular-Kidney-Metabolic Syndrome in Chinese and US Populations Shidi Hu, Dongmei Wang, Qingtao Yu, Zhi Chen, Weiguo Lu, Yuan Meng, Xuetao Peng, Lan Liu, Heng Wan, Jie Shen Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 4699. CrossRef
First
Prev
